# An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C

> **NCT03423641** · — · COMPLETED · sponsor: **Kaiser Permanente** · enrollment: 33808 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** Direct Acting Antivirals

## Key facts

- **NCT ID:** NCT03423641
- **Lead sponsor:** Kaiser Permanente
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 33808 (ACTUAL)
- **Last updated:** 2019-08-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03423641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03423641, "An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03423641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*